ID   SS-ES-1
AC   CVCL_A681
DR   Cosmic; 1483097
DR   Wikidata; Q54955681
RX   PubMed=20962673;
CC   Population: Iranian.
CC   Doubling time: 35 hours (PubMed=20962673).
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1 (PubMed=20962673).
CC   Derived from site: In situ; Chest, soft tissue; UBERON=UBERON_0001443+UBERON_0034929.
DI   NCIt; C7542; Askin tumor
DI   ORDO; Orphanet_370348; Peripheral primitive neuroectodermal tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   16Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 19-12-24; Version: 15
//
RX   PubMed=20962673; DOI=10.1097/MPH.0b013e3181ee4d16;
RA   Rajabalian S., Hajializadeh Z., Pooraboli I., Jangi-Aghdam H.,
RA   Badinloo M.;
RT   "Establishment, characterization, and drug sensitivity of a new Ewing
RT   sarcoma cell line (SS-ES-1).";
RL   J. Pediatr. Hematol. Oncol. 32:e331-e337(2010).
//